These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma. Perel RD; Slaughter RE; Strugnell WE J Cardiovasc Magn Reson; 2006; 8(6):789-91. PubMed ID: 17060100 [TBL] [Abstract][Full Text] [Related]
14. Anthracycline cardiotoxicity in childhood. Ruggiero A; Ridola V; Puma N; Molinari F; Coccia P; De Rosa G; Riccardi R Pediatr Hematol Oncol; 2008 Jun; 25(4):261-81. PubMed ID: 18484471 [TBL] [Abstract][Full Text] [Related]
15. Genotyping the risk of anthracycline-induced cardiotoxicity. Deng S; Wojnowski L Cardiovasc Toxicol; 2007; 7(2):129-34. PubMed ID: 17652817 [TBL] [Abstract][Full Text] [Related]
16. Cardiac safety, risk management, and oncology drug development. Fingert HJ; Varterasian ML Clin Cancer Res; 2006 Jun; 12(12):3646-7. PubMed ID: 16778090 [No Abstract] [Full Text] [Related]
17. Anthracyclines: cardiotoxicity and its prevention. Hale JP; Lewis IJ Arch Dis Child; 1994 Nov; 71(5):457-62. PubMed ID: 7826122 [No Abstract] [Full Text] [Related]
18. Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines. Pouillart P Cancer Treat Rev; 2004 Nov; 30(7):643-50. PubMed ID: 15531396 [TBL] [Abstract][Full Text] [Related]
19. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Conklin KA Integr Cancer Ther; 2005 Jun; 4(2):110-30. PubMed ID: 15911925 [TBL] [Abstract][Full Text] [Related]
20. Anthracycline cardiotoxicity: one size does not fit all! Hershman DL; Neugut AI J Natl Cancer Inst; 2008 Aug; 100(15):1046-7. PubMed ID: 18664649 [No Abstract] [Full Text] [Related] [Next] [New Search]